Jamison Wright 5/20/22 Jamison Wright 5/20/22 Ex-Takeda exec hits the ground running at the helm of rare disease biotech — with 3 priorities off the bat Read More Jamison Wright 2/1/22 Jamison Wright 2/1/22 Takeda spins PhII rare disease programs into new startup — sending 2 execs and some cash to get things going Read More Jamison Wright 2/1/22 Jamison Wright 2/1/22 New start-up Oak Hill to advance ‘de-prioritized’ Takeda rare disease candidates Read More Jamison Wright 2/1/22 Jamison Wright 2/1/22 Takeda shunts jewel of Shire takeover to new spinoff Oak Hill Read More
Jamison Wright 5/20/22 Jamison Wright 5/20/22 Ex-Takeda exec hits the ground running at the helm of rare disease biotech — with 3 priorities off the bat Read More
Jamison Wright 2/1/22 Jamison Wright 2/1/22 Takeda spins PhII rare disease programs into new startup — sending 2 execs and some cash to get things going Read More
Jamison Wright 2/1/22 Jamison Wright 2/1/22 New start-up Oak Hill to advance ‘de-prioritized’ Takeda rare disease candidates Read More
Jamison Wright 2/1/22 Jamison Wright 2/1/22 Takeda shunts jewel of Shire takeover to new spinoff Oak Hill Read More
